Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
Molecular Immunology
|
February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation
Annegret Bitzer, Michael Basler, Daniel Krappmann, et al.
European Journal of Immunology
|
July 21, 2020
Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation
Tobias Held, Michael Basler, Klaus-Peter Knobeloch, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 2011
The antiviral immune response in mice devoid of immunoproteasome activity
Michael Basler, Ulrike Beck, Christopher J Kirk, et al.
Brain, Behavior, and Immunity
|
October 27, 2010
Attenuation of the cytotoxic T lymphocyte response to lymphocytic choriomeningitis virus in mice subjected to chronic social stress
Annette Sommershof, Michael Basler, Carsten Riether, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 6, 2019
Immunoproteasome Inhibition Selectively Kills Human CD14<sup>+</sup> Monocytes and as a Result Dampens IL-23 Secretion
Michael Basler, Meike Claus, Moritz Klawitter, et al.
Oncoimmunology
|
December 19, 2022
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition
Julia Koerner, Dennis Horvath, Franziska Oliveri, et al.
European Journal of Immunology
|
November 26, 2010
Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice
Jacqueline Moebius, Maries van den Broek, Marcus Groettrup, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2012
Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation
Khalid W Kalim, Michael Basler, Christopher J Kirk, et al.
Clinical and Experimental Rheumatology
|
October 13, 2015
The immunoproteasome: a novel drug target for autoimmune diseases
Michael Basler, Sarah Mundt, Annegret Bitzer, et al.
Plos One
|
May 6, 2025
The ubiquitin-like modifier FAT10 does not affect IL-12 expression and signaling
Jinjing Cao, Gerardo Omar Alvarez Salinas, Gunter Schmidtke, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
Molecular Immunology
|
February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation
Annegret Bitzer, Michael Basler, Daniel Krappmann, et al.
European Journal of Immunology
|
July 21, 2020
Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation
Tobias Held, Michael Basler, Klaus-Peter Knobeloch, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 2011
The antiviral immune response in mice devoid of immunoproteasome activity
Michael Basler, Ulrike Beck, Christopher J Kirk, et al.
Brain, Behavior, and Immunity
|
October 27, 2010
Attenuation of the cytotoxic T lymphocyte response to lymphocytic choriomeningitis virus in mice subjected to chronic social stress
Annette Sommershof, Michael Basler, Carsten Riether, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 6, 2019
Immunoproteasome Inhibition Selectively Kills Human CD14<sup>+</sup> Monocytes and as a Result Dampens IL-23 Secretion
Michael Basler, Meike Claus, Moritz Klawitter, et al.
Oncoimmunology
|
December 19, 2022
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition
Julia Koerner, Dennis Horvath, Franziska Oliveri, et al.
European Journal of Immunology
|
November 26, 2010
Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice
Jacqueline Moebius, Maries van den Broek, Marcus Groettrup, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2012
Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation
Khalid W Kalim, Michael Basler, Christopher J Kirk, et al.
Clinical and Experimental Rheumatology
|
October 13, 2015
The immunoproteasome: a novel drug target for autoimmune diseases
Michael Basler, Sarah Mundt, Annegret Bitzer, et al.
Plos One
|
May 6, 2025
The ubiquitin-like modifier FAT10 does not affect IL-12 expression and signaling
Jinjing Cao, Gerardo Omar Alvarez Salinas, Gunter Schmidtke, et al.
Page
of 8